THE ROPPONGI CLINIC Introduces DEXIS OP 3D Vision V17 State-of-the-Art CT Device
NQ Score
90/100
N1 Content Completeness
95
AI Summary (NQ-processed)
THE ROPPONGI CLINIC has introduced the DEXIS OP 3D Vision V17 CT device, enabling high-resolution 3D imaging and low-dose radiation (11μSv) for precise in-house aesthetic surgery simulations and diagnosis.
AI Analysis
Frequently Asked Questions
- Q: What is the name of the clinic that introduced the state-of-the-art CT, and what is the model name of the device?
- A: The clinic is "THE ROPPONGI CLINIC" and the introduced CT is "DEXIS OP 3D Vision V17".
- Q: What is the radiation exposure level of the newly introduced CT?
- A: It is approximately 11 μSv per scan in the Quick Scan low-exposure mode, which is significantly lower than the approximately 10,000 μSv of a typical high-dose CT.
- Q: What is the purpose of introducing this CT?
- A: To enable more precise diagnosis, pre-operative simulation, and counseling in cosmetic surgery areas such as contouring and rhinoplasty, fully in-house.
- Q: Where is THE ROPPONGI CLINIC Roppongi Clinic located?
- A: It is located at 5th Floor, Uni Roppongi Building, 7-15-17 Roppongi, Minato-ku, Tokyo.
- Q: Which company is issuing this press release?
- A: TRC Co., Ltd. (株式会社TRC).